LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| MDA-MB-231 | YM 201636 | 0.2413 |
| MCF 10A | Momelotinib | 0.2434 |
| BT-20 | AZD8330 | 0.2496 |
| Hs 578T | Saracatinib | 0.2511 |
| BT-20 | Afatinib | 0.2554 |
| MCF 10A | Saracatinib | 0.2574 |
| BT-20 | PD0325901 | 0.2605 |
| MCF 10A | HG-5-88-01 | 0.2644 |
| BT-20 | WZ-4-145 | 0.2649 |
| MDA-MB-231 | OSI-027 | 0.2659 |
| SK-BR-3 | KIN001-043 | 0.2662 |
| SK-BR-3 | CHIR-99021 | 0.2680 |
| BT-20 | Trametinib | 0.2698 |
| SK-BR-3 | XMD11-85h | 0.2720 |
| MDA-MB-231 | Canertinib | 0.2722 |
| SK-BR-3 | AZD-6482 | 0.2743 |
| Hs 578T | R406 | 0.2744 |
| MCF 10A | QL-X-138 | 0.2745 |
| SK-BR-3 | Linsitinib | 0.2753 |
| BT-20 | Canertinib | 0.2763 |
| SK-BR-3 | Fedratinib | 0.2768 |
| BT-20 | NVP-TAE684 | 0.2851 |
| SK-BR-3 | PD0325901 | 0.2859 |
| Hs 578T | Pelitinib | 0.2873 |
| MCF7 | LDN-193189 | 0.2909 |